IBDEI0Y7 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16979,0)
 ;;=Q2049^^109^1065^35^^^^1
 ;;^UTILITY(U,$J,358.3,16979,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16979,1,1,0)
 ;;=1^Q2049
 ;;^UTILITY(U,$J,358.3,16979,1,3,0)
 ;;=3^Doxorubicin HCl,Liposomal 10mg
 ;;^UTILITY(U,$J,358.3,16980,0)
 ;;=J3489^^109^1065^88^^^^1
 ;;^UTILITY(U,$J,358.3,16980,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16980,1,1,0)
 ;;=1^J3489
 ;;^UTILITY(U,$J,358.3,16980,1,3,0)
 ;;=3^Zoledronic Acid 1mg
 ;;^UTILITY(U,$J,358.3,16981,0)
 ;;=J9219^^109^1065^55^^^^1
 ;;^UTILITY(U,$J,358.3,16981,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16981,1,1,0)
 ;;=1^J9219
 ;;^UTILITY(U,$J,358.3,16981,1,3,0)
 ;;=3^Lupron Acetate Implant 65mg
 ;;^UTILITY(U,$J,358.3,16982,0)
 ;;=J0641^^109^1065^54^^^^1
 ;;^UTILITY(U,$J,358.3,16982,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16982,1,1,0)
 ;;=1^J0641
 ;;^UTILITY(U,$J,358.3,16982,1,3,0)
 ;;=3^Levoleucovorin Calcium 0.5mg
 ;;^UTILITY(U,$J,358.3,16983,0)
 ;;=J0894^^109^1065^28^^^^1
 ;;^UTILITY(U,$J,358.3,16983,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16983,1,1,0)
 ;;=1^J0894
 ;;^UTILITY(U,$J,358.3,16983,1,3,0)
 ;;=3^Decitabine 1mg
 ;;^UTILITY(U,$J,358.3,16984,0)
 ;;=J0897^^109^1065^29^^^^1
 ;;^UTILITY(U,$J,358.3,16984,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16984,1,1,0)
 ;;=1^J0897
 ;;^UTILITY(U,$J,358.3,16984,1,3,0)
 ;;=3^Denosumab 1mg
 ;;^UTILITY(U,$J,358.3,16985,0)
 ;;=J1453^^109^1065^42^^^^1
 ;;^UTILITY(U,$J,358.3,16985,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16985,1,1,0)
 ;;=1^J1453
 ;;^UTILITY(U,$J,358.3,16985,1,3,0)
 ;;=3^Fosaprepitant 1mg
 ;;^UTILITY(U,$J,358.3,16986,0)
 ;;=J1710^^109^1065^46^^^^1
 ;;^UTILITY(U,$J,358.3,16986,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16986,1,1,0)
 ;;=1^J1710
 ;;^UTILITY(U,$J,358.3,16986,1,3,0)
 ;;=3^Hydrocortisone Sodium Phos up to 50mg
 ;;^UTILITY(U,$J,358.3,16987,0)
 ;;=J2150^^109^1065^58^^^^1
 ;;^UTILITY(U,$J,358.3,16987,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16987,1,1,0)
 ;;=1^J2150
 ;;^UTILITY(U,$J,358.3,16987,1,3,0)
 ;;=3^Mannitol 25% in 50 ml
 ;;^UTILITY(U,$J,358.3,16988,0)
 ;;=J2354^^109^1065^68^^^^1
 ;;^UTILITY(U,$J,358.3,16988,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16988,1,1,0)
 ;;=1^J2354
 ;;^UTILITY(U,$J,358.3,16988,1,3,0)
 ;;=3^Octreotide IV 1mg
 ;;^UTILITY(U,$J,358.3,16989,0)
 ;;=J2997^^109^1065^5^^^^1
 ;;^UTILITY(U,$J,358.3,16989,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16989,1,1,0)
 ;;=1^J2997
 ;;^UTILITY(U,$J,358.3,16989,1,3,0)
 ;;=3^Alteplase Recombinant 1mg
 ;;^UTILITY(U,$J,358.3,16990,0)
 ;;=J3262^^109^1065^83^^^^1
 ;;^UTILITY(U,$J,358.3,16990,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16990,1,1,0)
 ;;=1^J3262
 ;;^UTILITY(U,$J,358.3,16990,1,3,0)
 ;;=3^Tocilizumab 1mg
 ;;^UTILITY(U,$J,358.3,16991,0)
 ;;=J9033^^109^1065^9^^^^1
 ;;^UTILITY(U,$J,358.3,16991,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16991,1,1,0)
 ;;=1^J9033
 ;;^UTILITY(U,$J,358.3,16991,1,3,0)
 ;;=3^Bendamustine HCl 1mg
 ;;^UTILITY(U,$J,358.3,16992,0)
 ;;=J9178^^109^1065^37^^^^1
 ;;^UTILITY(U,$J,358.3,16992,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16992,1,1,0)
 ;;=1^J9178
 ;;^UTILITY(U,$J,358.3,16992,1,3,0)
 ;;=3^Epirubicin HCl 2mg
 ;;^UTILITY(U,$J,358.3,16993,0)
 ;;=J9305^^109^1065^75^^^^1
 ;;^UTILITY(U,$J,358.3,16993,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16993,1,1,0)
 ;;=1^J9305
 ;;^UTILITY(U,$J,358.3,16993,1,3,0)
 ;;=3^Pemetrexed 10mg
 ;;^UTILITY(U,$J,358.3,16994,0)
 ;;=P9010^^109^1066^22^^^^1
 ;;^UTILITY(U,$J,358.3,16994,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16994,1,1,0)
 ;;=1^P9010
 ;;^UTILITY(U,$J,358.3,16994,1,3,0)
 ;;=3^Whole Blood,Ea Unit
